[Transfer factor effectiveness patients with persistent genital human papillomavirus infection]

Blanca María Morfin-Maciel1, Julieta Margarita Sotelo-Ortiz

  • 1Anexo Hospital Angeles Mocel, Ignacio Esteva 107 consultorio 206, MÈxico 11850 D.F. blancamorfin@hotmail.com.

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|September 7, 2013
PubMed
Summary

Transfer factor (TF) effectively resolved genital lesions in women with persistent human papillomavirus (HPV) infections. This immunomodulator treatment prevented recurrences for at least one year, offering a novel therapeutic approach.